Back

Microcirculatory and metabolic adaptations to SGLT2 inhibitor therapy in chronic heart failure

10 May 2026 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: Enhanced aspects of clinical care Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Miss Maria Tarnawska

Medical University of Gdansk, Gdansk (Poland)

6 More presentations in this session

Presentation thumbnail
Factors associated with NT-proBNP reduction in acute heart failure: a secondary analysis of the PREMIER trial
Doctor Y. Nabeshima (Saga, JP)
Abstract Slides Video
Presentation thumbnail
Long term follow-up of autosomal recessive atrial dilated cardiomyopathy associated with mutation of natriuretic peptide precursor A
Doctor M. Iseppi (Trento, IT)
Abstract Slides Video
Presentation thumbnail
Operational characteristics of a clinical algorithm to optimize the detection of undiagnosed heart failure in primary care: insights from a prospective, multicenter study
Professor S. Stewart (Fremantle, AU)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence-enabled electrocardiography for identifying heart failure in patients with dyspnea in the emergency department
Associate Professor J. Park (Seongnam, KR)
Abstract Slides Video
Presentation thumbnail
AI-enabled ECG imaging for the detection of cardiac amyloidosis across amyloidosis subtypes
Miss A. Achten (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Enhanced aspects of clinical care

The Event

Event poster

Heart Failure 2026

10 May 2026 15:30 CET
You may be interested in
thumbnail
Congress Presentation
The effect of dapagliflozin on the microvascular endothelial cell function and metabolism in patients with heart failure: a preliminary report
thumbnail
Congress Presentation
The effect of SGLT2 inhibitors in peripheral tissue oxygenation in patients with heart failure; A Near-infrared spectroscopy study
thumbnail
Congress Presentation
Mechanistic insights of SGLT2 inhibitors effectiveness

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources